Literature DB >> 12920699

Environmental tobacco smoke and ischemic heart disease.

Malcolm R Law1, Nicholas J Wald.   

Abstract

Cohort and case control studies show a 30% excess risk of ischemic heart disease in nonsmokers whose spouses smoke compared with that in nonsmokers whose spouses do not smoke. There is a nonlinear dose-response; the excess risk from actively smoking 20 cigarettes/day is only 80%. Large cohort studies of active smoking support the nonliner dose-response (the excess risk in smokers of 5 cigarettes/day is about 50%). Animal studies show a pronounced vascular effect of environmental tobacco smoke. In experimental studies passive and active smoking have similar effects on platelet aggregation. The collective evidence supports a significant effect of low dose tobacco smoke exposure in causing ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920699     DOI: 10.1016/s0033-0620(03)00078-1

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  37 in total

1.  How acute and reversible are the cardiovascular risks of secondhand smoke?

Authors:  Terry F Pechacek; Stephen Babb
Journal:  BMJ       Date:  2004-04-24

2.  [Why must we support the laws on smoke free zones?].

Authors:  César Minué Lorenzo; Eduardo Olano Espinosa; José Vizcaíno Sánchez-Rodrigo
Journal:  Aten Primaria       Date:  2010-04-07       Impact factor: 1.137

Review 3.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

4.  Secondhand smoke exposure and osteoporosis in never-smoking postmenopausal women: the Fourth Korea National Health and Nutrition Examination Survey.

Authors:  K H Kim; C M Lee; S M Park; B Cho; Y Chang; S G Park; K Lee
Journal:  Osteoporos Int       Date:  2012-04-25       Impact factor: 4.507

5.  Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period.

Authors:  Jayadeep Patra; Benjamin Taylor; Jürgen T Rehm; Dolly Baliunas; Svetlana Popova
Journal:  Can J Public Health       Date:  2007 May-Jun

6.  Low-dose nonlinear effects of smoking on coronary heart disease risk.

Authors:  Louis Anthony Tony Cox
Journal:  Dose Response       Date:  2011-10-14       Impact factor: 2.658

7.  Use of E-Cigarettes Among Current Smokers: Associations Among Reasons for Use, Quit Intentions, and Current Tobacco Use.

Authors:  Lila J Finney Rutten; Kelly D Blake; Amenah A Agunwamba; Rachel A Grana; Patrick M Wilson; Jon O Ebbert; Janet Okamoto; Scott J Leischow
Journal:  Nicotine Tob Res       Date:  2015-01-14       Impact factor: 4.244

8.  Exposure to acrolein by inhalation causes platelet activation.

Authors:  Srinivas D Sithu; Sanjay Srivastava; Maqsood A Siddiqui; Elena Vladykovskaya; Daniel W Riggs; Daniel J Conklin; Petra Haberzettl; Timothy E O'Toole; Aruni Bhatnagar; Stanley E D'Souza
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-03       Impact factor: 4.219

Review 9.  The biology behind the atherothrombotic effects of cigarette smoke.

Authors:  Adam Csordas; David Bernhard
Journal:  Nat Rev Cardiol       Date:  2013-02-05       Impact factor: 32.419

10.  Risk of Cardiovascular Disease from Cumulative Cigarette Use and the Impact of Smoking Intensity.

Authors:  Jay H Lubin; David Couper; Pamela L Lutsey; Mark Woodward; Hiroshi Yatsuya; Rachel R Huxley
Journal:  Epidemiology       Date:  2016-05       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.